Intravenous (IV) Iron Drugs : Global Market Analysis, Trends, Size, and Forecasts to 2025

Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.

Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.

Download FREE Sample of this Report @

The global Intravenous (IV) Iron Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025.

This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Iron Drugs in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Intravenous (IV) Iron Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

  • Sanofi
  • Allergan
  • AMAG Pharmaceuticals
  • Dalichi Sankyo
  • Luitpold Pharmaceuticals
  • Pharmacosmos
  • Takeda Pharmaceutical

Segment by Regions

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Segment by Type

  • Ferric Carboxymaltose
  • Iron Sucrose
  • Iron Dextran
  • Others

Segment by Application

  • Nephrology
  • Gynecology & Obstetrics
  • Gastroenterology
  • Oncology
  • Cardiology
  • Others

Get the Complete Report & TOC @

Table of content

Executive Summary
1 Industry Overview of Intravenous (IV) Iron Drugs

1.1 Definition of Intravenous (IV) Iron Drugs
1.2 Intravenous (IV) Iron Drugs Segment by Type
1.2.1 Global Intravenous (IV) Iron Drugs Production Growth Rate Comparison by Types (2014–2025)
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Intravenous (IV) Iron Drugs Segment by Applications
1.3.1 Global Intravenous (IV) Iron Drugs Consumption Comparison by Applications (2014–2025)
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Global Intravenous (IV) Iron Drugs Overall Market
1.4.1 Global Intravenous (IV) Iron Drugs Revenue (2014–2025)
1.4.2 Global Intravenous (IV) Iron Drugs Production (2014–2025)
1.4.3 North America Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)
1.4.4 Europe Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)
1.4.5 China Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)
1.4.6 Japan Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)
1.4.7 Southeast Asia Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)
1.4.8 India Intravenous (IV) Iron Drugs Status and Prospect (2014–2025)

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :-